These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 34140296)
21. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial. Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M; Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830 [TBL] [Abstract][Full Text] [Related]
22. Impact of an interstitial lung disease service in the diagnosis and management of interstitial lung disease in Singapore. Chai GT; Tan TC; Lee YS; Kaw GJ; Chuah KL; Lim YJ; Abisheganaden JA; Thong BY Singapore Med J; 2020 Jun; 61(6):302-307. PubMed ID: 31317200 [TBL] [Abstract][Full Text] [Related]
23. Diagnostic Classification of Interstitial Lung Disease in Clinical Practice. Adegunsoye A; Ryerson CJ Clin Chest Med; 2021 Jun; 42(2):251-261. PubMed ID: 34024401 [TBL] [Abstract][Full Text] [Related]
28. Role of the occupational disease consultant in the multidisciplinary discussion of interstitial lung diseases. Carlier S; Nasser M; Fort E; Lamouroux C; Si-Mohamed S; Chalabreysse L; Maury JM; Diesler R; Cottin V; Charbotel B Respir Res; 2022 Dec; 23(1):332. PubMed ID: 36482462 [TBL] [Abstract][Full Text] [Related]
29. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease. Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002 [TBL] [Abstract][Full Text] [Related]
30. A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease. Wong AW; Lee TY; Johannson KA; Assayag D; Morisset J; Fell CD; Fisher JH; Shapera S; Gershon AS; Cox G; Halayko AJ; Hambly N; Manganas H; Sadatsafavi M; Wilcox PG; To T; Marcoux V; Khalil N; Kolb M; Ryerson CJ Respir Res; 2020 Dec; 21(1):322. PubMed ID: 33287805 [TBL] [Abstract][Full Text] [Related]
32. Progressive fibrosing interstitial lung diseases: current practice in diagnosis and management. Wijsenbeek M; Kreuter M; Olson A; Fischer A; Bendstrup E; Wells CD; Denton CP; Mounir B; Zouad-Lejour L; Quaresma M; Cottin V Curr Med Res Opin; 2019 Nov; 35(11):2015-2024. PubMed ID: 31328965 [No Abstract] [Full Text] [Related]
35. Interstitial lung disease on the acute take for the non-respiratory physician. Yioe V; Phillips G; Spencer LG Clin Med (Lond); 2021 Nov; 21(6):e584-e590. PubMed ID: 34862217 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis. Olson AL; Patnaik P; Hartmann N; Bohn RL; Garry EM; Wallace L Adv Ther; 2021 Jul; 38(7):4100-4114. PubMed ID: 34156606 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]